Sixty patients who received 75 consecutive liver grafts and had routine Doppler sonography monitoring in the early postoperative period (three times a day) were reviewed for vascular complications. Thrombosis of the hepatic artery was detected in seven patients (3, 4, 20, 24, 48, 70 and 84 h after liver transplantation) and was then confirmed by emergency laparotomy in six cases. In one patient, thrombosis was verified by angiography before laparotomy. In two patients thrombectomy was successful, in five patients retransplantation had to be performed. Portal vein occlusion was detected in three patients (24, 26 and 90 h after transplantation) and all were successfully treated by thrombectomy and partial arterialization of the portal vein. Colour Doppler sonography was associated with no false-positive or -negative results. The specificity was 100% for the diagnosis of hepatic artery and portal vein thrombosis. In our opinion colour Doppler sonography will be able to replace time-consuming angiography in vascular diagnostics in the early postoperative phase after liver transplantation. Furthermore, there is evidence that frequent use of this non-invasive technique permits early detection of clinically unsuspected vascular complications and subsequent immediate relaparotomy, which is linked to a reduction in the rate of retransplantation.
Bedeutung der farbdopplersonographie für die entdeckung einer thrombose der A. hepatica und der V. portae nach Lebertransplantation
Zusammenfassung Bei 60 Patienten nach Lebertransplantation (75 Transplantate) wurde in der ersten postoperativen Woche dreimal täglich eine farbcodierte Dopplersonographie zum Ausschlu vaskulärer Komplikationen durchgeführt. Eine Thrombose der Leberarterie wurde bei 7 Patienten diagnostiziert (3, 4, 20, 24, 48, 70 und 84 h nach der Transplantation). Die Diagnose wurde intraoperativ bei Relaparotomie bestätigt, bei einem Patienten erfolgte vor der Revisionsoperation eine Angiographie. Zweimal war eine Thrombektomie der Leberarterie erfolgreich, bei fünf Patienten mute retransplantiert werden. Eine Pfortaderthrombose wurde bei drei Patienten (24, 26 und 90 h nach der Transplantation) diagnostiziert. Immer war eine Thrombektomie mit partieller Arterialisierung der Pfortader erfolgreich. Falsch negative bzw. falsch positive Befunde wurden nicht erhoben, so da die farbcodierte Dopplersonographie mit einer hohen Sensitivität bei einer Spezifität von 100% in der Diagnose von Gefäßkomplikationen nach Lebertransplantation verbunden ist. In der Diagnostik von Gefäßkomplikationen während der frühen postoperativen Phase nach Lebertransplantationen kann die Angiographie durch die farbcodierte Dopplersonographie ersetzt werden. Die Diagnose insbesondere von klinisch noch nicht manifesten Gefäßkomplikationen ist durch engmaschigen Einsatz der Methode möglich und kann durch frühzeitige Relaparotomie zu einer Senkung der Retransplantationsrate führen.
PurposeA meta-analysis aimed to systematically evaluate the safety and efficiency of I125 irradiation stent placement for patients with hepatocellular carcinoma (HCC) combined with portal vein tumor thrombosis (PVTT).Materials and methodsThe Cochrane library, PubMed/Medline, EMBASE, CNKI, Wanfang Data and CQVIP were systematically screened out from the earliest to December 2019. The qualities of all included studies were assessed. The primary endpoints were the 6-month, 12-month stent cumulative patency rate and 6-month, 12-month, 24-month overall survival rate while the secondary endpoints were the objective response rate of PVTT, main portal venous pressure changes and treatment-related adverse events. Our meta-analysis was conducted using Stata 12.0 software.ResultsTotally seven studies with 1018 patients were included in the final analysis, in which 602 patients received TACE and I125 irradiation stent placement, and 416 patients in control group underwent TACE and stent placement without endovascular brachytherapy (EVBT). Meta-analysis showed that the I125 irradiation stent improved the cumulative stent patency rates in 6 months [OR = 1.65, 95% CI (1.32–2.05), P < 0.001] and 12 months [OR = 2.55, 95% CI (1.90–3.42), P < 0.001] and the survival rates in 6 months [OR = 1.77, 95% CI (1.41–2.22), P < 0.001], 12 months [OR = 3.14, 95% CI (2.24–4.40), P < 0.001] and 24 months [OR = 7.39, 95% CI (3.55–15.41), P < 0.001]. However, there was no difference in the objective response rate of PVTT [OR = 1.13, 95% CI (0.87–1.48), P = 0.365], main portal venous pressure and the occurrence adverse event [OR = 0.88, CI = 0.72–1.08, P = 0.212] between two groups.ConclusionI125 irradiation stent seems to be more effective in treating hepatocellular carcinoma with portal vein tumor thrombosis. The usage of portal vein stent combined endovascular brachytherapy has the potential to act as an alternative therapy for HCC with PVTT. On account of the limitation of studies included, more studies with high-level evidence, such as RCTs, are requisite to support the above promising results. 相似文献
Deep vein thrombosis is a frequent disease with an annual incidence reaching 5 per thousand among subjects over 75 years. Major acquired risk factors for venous thrombosis include surgery, neoplasm, reduced mobility or paresis, and a previous episode of deep vein thrombosis. Among women, hormonal status (pregnancy, oral contraceptive, hormone replacement therapy) is responsible for the majority of all venous thrombotic events. The impact of other factors is controversial: obesity, tobacco use and varicose veins. Venous thrombosis is a multifactorial disease and analysis of the interactions between acquired and inherited risk factors is an extremely interesting field of investigation. 相似文献